Citadel Advisors’s SeaStar Medical ICU Stock Holding History
Bought
Maintained
Sold
Other funds holding ICU
CCFM
SWA
TRCT
WAM
Citadel Advisors's ICU Position: Q4 2022 in Review
Citadel Advisors sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 259 shares — an estimated $666K sold.
Citadel Advisors first reported a position in ICU in Q1 2021 and held it in 7 quarters. The position peaked at $674K in Q3 2021. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.
- Citadel Advisors reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
- Citadel Advisors sold 259 SeaStar Medical shares in Q4 2022, an estimated $666K.
- Citadel Advisors first reported a position in SeaStar Medical in Q1 2021 and held it in 7 quarters.
- Citadel Advisors's SeaStar Medical position peaked at $674K in Q3 2021.
- 8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.
Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.